Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methotrexate Induced Nephrotoxicity”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableStudy completedNCT00570817
What this trial is testing

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

Who this might be right for
Methotrexate Induced Nephrotoxicity
University of Aarhus 47
Post-approval studies (Phase 4)Not Yet RecruitingNCT06641128
What this trial is testing

The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)Methotrexate Induced NephrotoxicityMethotrexate Adverse Reaction
Tanta University 44
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13